GoldsteinEJ, CitronDM, PerainoV, ElgourtT, MeibohmAR, LuS. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother2009; 53: 5122–6. DOI: 10.1128/AAC.00064-09
2.
EagyeKJ, NicolauDP. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals. Infect Control Hosp Epidemiol2010; 31: 485–90. DOI: 10.1086/652154
3.
GoffDA, ManginoJE. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect2008; 57: 123–7. DOI: 10.1016/j.jinf.2008.06.001
4.
LimaAL, OliveiraPR, PaulaAP, Dal-PazK, RossiF, ZumiottiAV. The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study. Infect Control Hosp Epidemiol2009; 30: 487–90. DOI 10.1086/596781
5.
HirschEB, ChangKT, LascoTM, CaeiroJP, TamVH. Emergence of KPC-producing Klebsiella pneumoniae in Texas. Diagn Microbiol Infect Dis2011; 69: 234–5. DOI: 10.1016/j.diagmicrobio.2010.09.003